Navigation Links
Lilly Reports Second-Quarter 2011 Results
Date:7/21/2011

exchange rates.

Alimta

For the second quarter of 2011, Alimta generated sales of $613.4 million, an increase of 11 percent compared with the second quarter of 2010. U.S. sales of Alimta decreased 1 percent, to $251.9 million, driven by decreased volume. Sales outside the U.S. increased 21 percent, to $361.5 million, due to increased demand, as well as the favorable impact of foreign exchange rates.

Humalog

For the second quarter of 2011, worldwide Humalog sales increased 16 percent, to $586.9 million. Sales in the U.S. increased 14 percent to $341.6 million, driven by increased demand and higher prices. Sales outside the U.S. increased 20 percent to $245.3 million, driven by higher demand and the favorable impact of foreign exchange rates.

Cialis

Cialis sales for the second quarter of 2011 increased 14 percent to $477.2 million. U.S. sales of Cialis were $180.3 million in the second quarter, a 9 percent increase compared with the second quarter of 2010, driven by increased demand and higher prices, partially offset by wholesaler buying patterns. Sales of Cialis outside the U.S. increased 17 percent, to $297.0 million, driven by the favorable impact of foreign exchange rates and increased demand.

Humulin

Worldwide Humulin sales increased 18 percent in the second quarter of 2011, to $311.8 million. U.S. sales increased 27 percent to $146.0 million, driven by increased demand for Humulin® ReliOn®, as well as higher prices for Humulin. Sales outside the U.S. increased 11 percent, to $165.8 million, driven by the favorable impact of foreign exchange rates and increased demand.

Evista

Evista sales were $263.5 million in the second quarter of 2011, a 2 percent increase compared with the second quarter of 2010. U.S. sales of Evista decreased 1 percent to $174.5 million, as a result of decreased demand, partially offset by higher prices. Sales outside the U.S. increased 6 percent to $89.0 million
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
2. Lilly and Argonne National Laboratory Announce $2 Million Upgrade to Lillys Beamline Capabilities
3. Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer
4. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
5. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
6. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
7. Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
8. Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
9. Lilly Declares Third-Quarter 2011 Dividend
10. Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform
11. Synthes and Lilly Sign Development and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  Cryoport, Inc. (NASDAQ: ... leading provider of advanced cryogenic logistics solutions ... including immunotherapies, stem cells, cell lines, clinical ... reproductive medicine, announced today that the Company ... warrants (the "Units") under a registered public offering.  ...
(Date:7/29/2015)... , July 29, 2015  Ortho-Clinical Diagnostics, Inc. ... assays under development. The assays address a range of ... injury and cardiac troponin I. The scientific posters will ... Chemistry Annual Meeting to be held July 26 - ... "Ortho Clinical Diagnostics is emerging stronger than ...
(Date:7/29/2015)... July 29, 2015 The Judicial Panel on ... about whether to centralize Inferior vena cava (IVC) Filter ... manufacturer, Cook Medical, have already been centralized by the ... in patients at risk for a pulmonary embolism. The ... to the lungs. Claims against Bard and Cook involve ...
Breaking Medicine Technology:Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... New results from an observational substudy from TRITON–TIMI ... (AHA) Scientific Sessions annual meeting showed that patients ... bypass graft surgery (CABG) had a reduced overall ... (clopidogrel) (2.3 percent versus 8.7 percent respectively, p=0.016).(1) ...
... Nov. 16, 2010 New results from an ... the American Heart Association (AHA) Scientific Sessions annual ... prior to coronary artery bypass graft surgery (CABG) ... patients treated with Plavix® (clopidogrel) (2.3 percent versus ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 6Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6
(Date:7/29/2015)... MI (PRWEB) , ... July 29, 2015 , ... ... for Southwest Michigan, changed its name in July to Kalamazoo Strength & Conditioning. ... http://www.kalamazoosc.com , and “reflects the evolution of our training center over the ...
(Date:7/29/2015)... ... 2015 , ... For the second year in a row, the management and ... 50 fastest growing companies in Jacksonville. This annual list is compiled by the Jacksonville ... team of Vast Bridges staffers were on hand to receive the award naming the ...
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... ... Petitions were approved by USCIS over the past month! I-829 approvals have been granted ... projects in Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the ...
(Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 article from ... ," discussed the importance of having regular skin cancer screenings from an early age. ... to ultraviolet rays. When caught early, skin cancer is rarely fatal; however, if left ...
(Date:7/29/2015)... ... July 29, 2015 , ... Several years ago, in order to be ... Little City took a proactive stance and began planning the Children’s Village consisting of ... valuable support to building the third home. , “We are very pleased to have ...
Breaking Medicine News(10 mins):Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Vast Bridges Continues Its Swift Growth 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3
... retailer,s $4 drug program the largest of its kind, ... its,commitment to improving the health and wellness of its ... this,Thursday, November 8, 2007, the company will expand its ... of more than 400. The program makes commonly ...
... to medication regimen, study finds , WEDNESDAY, Nov. 7 ... with high blood pressure stick to the drug regimens ... , Older black Americans tend to have poorer anti-hypertensive ... even though adherence helps reduce hypertension-related health problems and ...
... SAN DIEGO, Nov. 7 CryoCor, Inc. (Nasdaq:,CRYO), a ... announced today that it will release its financial results ... 13, 2007 after,the close of the U.S. financial markets. ... conference call at 5:00 p.m. ET /,2:00 p.m. PT ...
... CLEVELAND, Nov. 7 JumpStart Inc., Northeast ... commitment of,$350,000 in Aria Analytics, Inc. Aria ... that measures the physical and chemical,attributes of ... acoustically,probing the sample during evaporation. (Logo: ...
... a mouse feels, thanks to a new technique which uses ... the brain which regulates appetite. , Researchers hope the ... greater understanding of why certain people become obese when others ... new study, led by researchers from Imperial College London, is ...
... on multiple fronts, researchers say , , WEDNESDAY, Nov. 7 ... VN/14-1 proved effective in treating human prostate cancer, say ... The five-week study found that daily injections of VN/14-1 ... in up to a 50 percent reduction in tumor ...
Cached Medicine News:Health News:Giant Eagle Expands Popular Generic Prescription Program and Now Offers '400 for $4' 2Health News:Spirituality Helps Older Black Women Beat Hypertension 2Health News:CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results 2Health News:Aria Analytics Receives JumpStart Investment 2Health News:Aria Analytics Receives JumpStart Investment 3Health News:Obesity research boosted by watching hunger in the brain 2Health News:Experimental Drug Fights Prostate Cancer 2
... Sorvall DiscoveryTMM150 SE Micro-ultra centrifuge continues to ... sample processing, now with 1,048,000 x g ... rotor. DiscoveryTMM150SE processes sample sizes from ... small floor footprint, brushless direct drive, very ...
... highest g-force ever. But optimal productivity in ... MAX combines maximum force, capacity, and ease ... worlds apart from any other system. With ... efficiency, Optima takes productivity to the MAX. ...
... Efficiency, versatility, and environmental ... the Optima LE-80 K Ultracentrifuge ... Coulters innovative Optima centrifugation technology, ... to cost effectively provide advanced ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
Medicine Products: